Deng Hanqiang, Eichmann Anne, Schwartz Martin A
Yale Cardiovascular Research Center CT (H.D., A.E., M.A.S.), Yale University School of Medicine, New Haven, CT.
Section of Cardiovascular Medicine, Department of Internal Medicine (H.D., A.E., M.A.S.), Yale University School of Medicine, New Haven, CT.
Arterioscler Thromb Vasc Biol. 2025 Jun;45(6):882-900. doi: 10.1161/ATVBAHA.125.322557. Epub 2025 Apr 10.
The vascular system remodels throughout life to ensure adequate perfusion of tissues as they grow, regress, or change metabolic activity. Angiogenesis, the sprouting of new blood vessels to expand the capillary network, versus regression, in which endothelial cells die or migrate away to remove unneeded capillaries, controls capillary density. In addition, upstream arteries adjust their diameters to optimize blood flow to downstream vascular beds, which is controlled primarily by vascular endothelial cells sensing fluid shear stress (FSS) from blood flow. Changes in capillary density and small artery tone lead to changes in the resistance of the vascular bed, which leads to changes in flow through the arteries that feed these small vessels. The resultant decreases or increases in FSS through these vessels then stimulate their inward or outward remodeling, respectively. This review summarizes our knowledge of endothelial FSS-dependent vascular remodeling, offering insights into potential therapeutic interventions. We first provide a historical overview, then discuss the concept of set point and mechanisms of low-FSS-mediated and high-FSS-mediated inward and outward remodeling. We then cover in vivo animal models, molecular mechanisms, and clinical implications. Understanding the mechanisms underlying physiological endothelial FSS-mediated vascular remodeling and their failure due to mutations or chronic inflammatory and metabolic stresses may lead to new therapeutic strategies to prevent or treat vascular diseases.
血管系统在整个生命过程中都会进行重塑,以确保随着组织生长、退化或代谢活动改变时能有足够的灌注。血管生成,即新血管的芽生以扩展毛细血管网络,与消退相反,消退过程中内皮细胞死亡或迁移以去除不需要的毛细血管,二者共同控制着毛细血管密度。此外,上游动脉会调节其直径,以优化向下游血管床的血流,这主要由感知血流产生的流体切应力(FSS)的血管内皮细胞控制。毛细血管密度和小动脉张力的变化会导致血管床阻力的改变,进而导致为这些小血管供血的动脉中血流的变化。通过这些血管的FSS的相应降低或增加,随后分别刺激它们的内向或外向重塑。本综述总结了我们对内皮FSS依赖性血管重塑的认识,为潜在的治疗干预提供见解。我们首先提供一个历史概述,然后讨论设定点的概念以及低FSS介导和高FSS介导的内向和外向重塑的机制。接着我们涵盖体内动物模型、分子机制和临床意义。了解生理性内皮FSS介导的血管重塑的潜在机制以及由于突变或慢性炎症和代谢应激导致的机制失效,可能会带来预防或治疗血管疾病的新治疗策略。